Correlation Between Jinhe Biotechnology and Longmaster Information

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Longmaster Information at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Longmaster Information into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and Longmaster Information Tech, you can compare the effects of market volatilities on Jinhe Biotechnology and Longmaster Information and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Longmaster Information. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Longmaster Information.

Diversification Opportunities for Jinhe Biotechnology and Longmaster Information

0.95
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Jinhe and Longmaster is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Longmaster Information Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longmaster Information and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Longmaster Information. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longmaster Information has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Longmaster Information go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Longmaster Information

Assuming the 90 days trading horizon Jinhe Biotechnology is expected to generate 1.46 times less return on investment than Longmaster Information. But when comparing it to its historical volatility, Jinhe Biotechnology Co is 1.99 times less risky than Longmaster Information. It trades about 0.23 of its potential returns per unit of risk. Longmaster Information Tech is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,124  in Longmaster Information Tech on September 23, 2024 and sell it today you would earn a total of  572.00  from holding Longmaster Information Tech or generate 50.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  Longmaster Information Tech

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Longmaster Information 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Longmaster Information Tech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Longmaster Information sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology and Longmaster Information Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and Longmaster Information

The main advantage of trading using opposite Jinhe Biotechnology and Longmaster Information positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Longmaster Information can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longmaster Information will offset losses from the drop in Longmaster Information's long position.
The idea behind Jinhe Biotechnology Co and Longmaster Information Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data